Comparison results
Add for comparison more than one drug or diagnosis.
| Results: Differences General | ✘Trachoma | |||
| Related research | Analogs | |||
| ||||
| Distinctive symptoms | ||||
| Register, to see more distinctive signs of diseases and studies | 31% | |||
| Register, to see more distinctive signs of diseases and studies | 28% | |||
| lacrimal ducts | 23% | |||
| conjunctivitis | 21% | |||
| keratopathy | 20% | |||
| keratitis | 20% | |||
| inflammatory infiltrate | 20% | |||
| chronic condition | 19% | |||
| viral conjunctivitis | 19% | |||
| inflammation of the eyes | 19% | |||
| frequent conjunctivitis | 19% | |||
| corneal dystrophy | 19% | |||
| conjunctivitis in children | 19% | |||
| pannus | 19% | |||
| in the morning discharge from the eyes | 18% | |||
| infectious eye diseases | 18% | |||
| dacryocystitis | 18% | |||
| canaliculitis | 18% | |||
| conjunctivitis purulent | 18% | |||
| chronic dacryocystitis | 18% | |||
| corneal opacity | 17% | |||
| sensation of a foreign body in the eye | 16% | |||
| chlamydia DNA positive | 16% | |||
| swelling of the conjunctiva | 16% | |||
| swelling of eyelids | 15% | |||
| dystrophy | 15% | |||
| clamidiosis | 15% | |||
| inflammation | 14% | |||
| foreign body sensation | 14% | |||
| scar inflammation | 14% | |||
| heaviness in the eyes | 14% | |||
| chronic conjunctivitis | 14% | |||
| hypopion | 14% | |||
| clamidiosis in women | 13% | |||
| history of surgery | 13% | |||
| edema of the upper eyelid | 13% | |||
| dryness in the ears | 13% | |||
| scarring | 13% | |||
| photophobia | 13% | |||
| inflammation of the mucous membrane of the eyes | 13% | |||
| bacterial keratitis | 12% | |||
| swelling | 12% | |||
| demodecosis of the eyelids | 12% | |||
| disorder demodecosis | 12% | |||
| xerophthalmia | 12% | |||
| acute viral keratitis | 12% | |||
| s eyes cloudy | 12% | |||
| inversion of the century | 12% | |||
| diathesis | 12% | |||
| conjunctiva red | 12% | |||
| inflammation of the appendages | 11% | |||
| wet eyes | 11% | |||
| ptosis of the upper eyelids | 11% | |||
| acute iritis | 11% | |||
| corneal ulcer | 11% | |||
| ulcer penetration | 11% | |||
| blepharitis | 11% | |||
| red eyelids | 11% | |||
| corneal edema | 11% | |||
| enophthalmos | 11% | |||
| constantly crying | 11% | |||
| scales on eyelids | 11% | |||
| malaria | 11% | |||
| burning in the eyes | 11% | |||
| pharyngitis | 10% | |||
| sputum green | 10% | |||
| skin lymphoma | 10% | |||
| lymphogranulomatosis | 10% | |||
| oncology | 9% | |||
| no discharge | 9% | |||
| lowered | 9% | |||
| intra-phase infections | 9% | |||
| lymphoma | 9% | |||
| discharge from the eyes | 9% | |||
| there are no complaints | 9% | |||
| dry skin | 9% | |||
| malignant lymphoma | 9% | |||
| myxedema | 9% | |||
| uveit | 9% | |||
| eye swelling | 9% | |||
| blindness | 8% | |||
| burns | 8% | |||
| pain in the eyes | 8% | |||
| visual impairment | 8% | |||
| tuberculosis | 8% | |||
| wet skin | 8% | |||
| periods of exacerbation | 8% | |||
| sputum | 8% | |||
| helminths | 8% | |||
| weakening of immunity | 8% | |||
| blurred vision | 8% | |||
| anesthesia | 7% | |||
| onset of illness | 7% | |||
| consequences of surgery | 7% | |||
| necrosis | 7% | |||
| allergy | 7% | |||
| dry | 7% | |||
| acute condition | 7% | |||
| increased sensitivity | 7% | |||
| immunodeficiency | 7% | |||
| vascular tumor | 7% | |||
| peptic ulcer | 7% | |||
| drug allergy | 7% | |||
| subacute condition | 7% | |||
| skin problems | 6% | |||
| consequences of taking medications | 6% | |||
| increased | 6% | |||
Instructions
Video 
- Introduce new diseases through 🔍 Search and input on the top panel using
- The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases.
- The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease.
- The list changes dynamically depending on the data of the current visit in the selection of therapy .
- Click on the percentageto see the suggestions from the original source.
- By using the service, you agree to user agreement.
